Vicore Pharma Holding AB (VICO.ST)
These figures are from 2023-12-31.
Nothing newer has been filed in the 33 months since.
Vicore Pharma Holding AB reported revenue of 0 SEK for the year ending 31 December 2023.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in SEK.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in SEK.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
2023 · ending 31 December 2023 |
0 |
— |
| Gross Profit |
2023 · ending 31 December 2023 |
0 |
— |
| Operating Income |
2023 · ending 31 December 2023 |
-321.5M |
— |
| Net Income |
2023 · ending 31 December 2023 |
-310.9M |
— |
| Operating Cash Flow |
2023 · ending 31 December 2023 |
-249.6M |
— |
| EPS |
2023 · ending 31 December 2023 |
-3.22 |
— |
Revenue and profit by financial year
As filed, in SEK. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
|---|
| 2023 | 2023-12-31 |
0 | -321.5M | -310.9M | — |
|---|
| 2022 | 2022-12-31 |
0 | -290.7M | -288.4M | — |
|---|
| 2021 | 2021-12-31 |
0 | -294.8M | -296.5M | — |
|---|
Every period
Revenue Annual
| Period | Ending | Revenue |
|---|
| FY23 | 2023-12-31 | 0 |
|---|
| FY22 | 2022-12-31 | 0 |
|---|
| FY21 | 2021-12-31 | 0 |
|---|
Gross Profit Annual
| Period | Ending | Gross Profit |
|---|
| FY23 | 2023-12-31 | 0 |
|---|
| FY22 | 2022-12-31 | 0 |
|---|
| FY21 | 2021-12-31 | 0 |
|---|
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| FY23 | 2023-12-31 | -321.5M |
|---|
| FY22 | 2022-12-31 | -290.7M |
|---|
| FY21 | 2021-12-31 | -294.8M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| FY23 | 2023-12-31 | -310.9M |
|---|
| FY22 | 2022-12-31 | -288.4M |
|---|
| FY21 | 2021-12-31 | -296.5M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| FY23 | 2023-12-31 | -249.6M |
|---|
| FY22 | 2022-12-31 | -299.9M |
|---|
| FY21 | 2021-12-31 | -265.2M |
|---|
EPS Annual
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
| Period | Ending | EPS |
|---|
| FY23 | 2023-12-31 | -3.22 |
|---|
| FY22 | 2022-12-31 | -3.99 |
|---|
| FY21 | 2021-12-31 | -4.25 |
|---|